M Sieniawski

Summary

Affiliation: University of Newcastle
Country: UK

Publications

  1. ncbi Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)
    A Josting
    First Department of Internal Medicine, University Hospital Cologne, Germany
    Ann Oncol 16:116-23. 2005
  2. doi Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategies
    Michal K Sieniawski
    Haematological Sciences, Newcastle University, Leech Building, Medical School, Newcastle upon Tyne, UK
    Curr Hematol Malig Rep 6:231-40. 2011
  3. doi Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation
    Michal Sieniawski
    Haematological Sciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, United Kingdom
    Blood 115:3664-70. 2010
  4. ncbi Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma
    Michal Sieniawski
    First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany
    J Clin Oncol 25:2000-5. 2007
  5. doi Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials
    M Sieniawski
    Department of Internal Medicine, University Hospital Cologne, Cologne, Germany
    Ann Oncol 19:1795-801. 2008
  6. ncbi Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)
    Michal Sieniawski
    Department of Internal Medicine, University Hospital Cologne, Cologne, Germany
    Blood 111:71-6. 2008
  7. ncbi High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study
    A Josting
    University Hospital Cologne, First Department of Internal Medicine, Germany
    Ann Oncol 16:1359-65. 2005
  8. doi Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
    Teresa V Halbsguth
    First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
    Blood 116:2026-32. 2010
  9. ncbi Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group
    Lucia Nogova
    First Department of Internal Medicine, University Hospital Cologne, Kerpenerstr 62, 50924 Cologne, Germany
    J Clin Oncol 26:434-9. 2008
  10. doi Hodgkin lymphoma in the elderly: a clinical review of treatment and outcome, past, present and future
    S J Proctor
    Haematological Sciences, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
    Crit Rev Oncol Hematol 71:222-32. 2009

Collaborators

Detail Information

Publications11

  1. ncbi Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)
    A Josting
    First Department of Internal Medicine, University Hospital Cologne, Germany
    Ann Oncol 16:116-23. 2005
    ..We designed a dose- and time-intensified high-dose sequential chemotherapy regimen for patients with relapsed and refractory Hodgkin lymphoma (HD)...
  2. doi Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategies
    Michal K Sieniawski
    Haematological Sciences, Newcastle University, Leech Building, Medical School, Newcastle upon Tyne, UK
    Curr Hematol Malig Rep 6:231-40. 2011
    ..This review summarizes recently published data on epidemiology and clinical features, as well as standard and novel treatments including high-dose chemotherapy with ASCT and their outcome in EATL...
  3. doi Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation
    Michal Sieniawski
    Haematological Sciences, Newcastle University, Newcastle upon Tyne, NE2 4HH, United Kingdom
    Blood 115:3664-70. 2010
    ..01 and P = .003, respectively). EATL is a rare lymphoma with an unfavorable prognosis when treated with conventional therapies. The IVE/MTX-ASCT regimen is feasible with acceptable toxicity and significantly improved outcome...
  4. ncbi Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma
    Michal Sieniawski
    First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany
    J Clin Oncol 25:2000-5. 2007
    ..To evaluate treatment outcome of patients with early-stage favorable Hodgkin's lymphoma (HL) who experience disease relapse after primary treatment with two cycles of chemotherapy followed by radiotherapy (RT)...
  5. doi Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials
    M Sieniawski
    Department of Internal Medicine, University Hospital Cologne, Cologne, Germany
    Ann Oncol 19:1795-801. 2008
    ..Infertility is one of the most significant side-effects in long-term survivors of successfully treated Hodgkin's lymphoma (HL)...
  6. ncbi Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)
    Michal Sieniawski
    Department of Internal Medicine, University Hospital Cologne, Cologne, Germany
    Blood 111:71-6. 2008
    ..Male patients with HL are at high risk of infertility after treatment with BEACOPP...
  7. ncbi High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study
    A Josting
    University Hospital Cologne, First Department of Internal Medicine, Germany
    Ann Oncol 16:1359-65. 2005
    ..High-dose chemotherapy (HDCT) with autologous stem cell transplantation (ASCT) can improve the outcome of these patients. We evaluated an intensified high-dose sequential chemotherapy program with a final myeloablative course...
  8. doi Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
    Teresa V Halbsguth
    First Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany
    Blood 116:2026-32. 2010
    ..Three patients died before response assessment. Thus, the BACOPP regimen is active in older HL patients but is compromised by a high rate of toxic deaths. This trial was registered at www.clinicaltrials.gov as #NCT00284271...
  9. ncbi Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group
    Lucia Nogova
    First Department of Internal Medicine, University Hospital Cologne, Kerpenerstr 62, 50924 Cologne, Germany
    J Clin Oncol 26:434-9. 2008
    ..To shed more light on the prognosis and outcome of LPHL, we reviewed all LPHL patients registered in the German Hodgkin Study Group (GHSG) database, comparing patient characteristics and treatment outcome with cHL patients...
  10. doi Hodgkin lymphoma in the elderly: a clinical review of treatment and outcome, past, present and future
    S J Proctor
    Haematological Sciences, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
    Crit Rev Oncol Hematol 71:222-32. 2009
    ..The SHIELD study (Study of Hodgkin lymphoma in the Elderly/Lymphoma Database) is a current example of an approach aimed at objectively defining some of the difficulties of this patient population...
  11. ncbi Successful carboxypeptidase G2 rescue of a high-risk elderly Hodgkin lymphoma patient with methotrexate intoxication and renal failure
    Michal Sieniawski
    Leuk Lymphoma 48:1641-3. 2007